Thinking of joining a study?

Register your interest

NCT04682574 | COMPLETED | Corona Virus Infection


Role of Mega Dose of Vitamin C in Critical COVID-19 Patients
Sponsor:

University of Lahore

Information provided by (Responsible Party):

Muhammad Monsor Hafeez

Brief Summary:

Vitamin C (ascorbic acid) is a water-soluble vitamin having anti-inflammatory, immunomodulatory, anti-oxidative, antithrombotic and antiviral properties. Considering these effects vitamin C should have beneficial impact in patients suffering from sepsis and acute respiratory distress syndrome (ARDS). The current study is designed to assess the beneficial effects of Vitamin C in COVID-19 infected patients.

Condition or disease

Corona Virus Infection

Intervention/treatment

Vitamin C

Phase

NA

Study Type : INTERVENTIONAL
Estimated Enrollment : 278 participants
Masking : SINGLE
Primary Purpose : TREATMENT
Official Title : Effects of Mega Dose Vitamin C in Critically Ill COVID-19 Patients: A Randomized Control Trial
Actual Study Start Date : 2020-11-02
Estimated Primary Completion Date : 2022-02-28
Estimated Study Completion Date : 2022-03-10

Information not available for Arms and Intervention/treatment

Ages Eligible for Study:
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers:
Criteria
Inclusion Criteria
  • critically ill patients admitted in ICU
Exclusion Criteria
  • allergic to Vitamin C didnt given the consent

Role of Mega Dose of Vitamin C in Critical COVID-19 Patients

Location Details

NCT04682574


Please Choose a site



How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

Locations


Not yet recruiting

Pakistan, Punjab

Bahria Town International Hospital

Lahore, Punjab, Pakistan, 54000

Loading...